Inhibrx Biosciences (INBX) Other financing activities (2023 - 2025)

Inhibrx Biosciences (INBX) has 3 years of Other financing activities data on file, last reported at $1.3 million in Q4 2025.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $1.6 million, a 97.76% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 97.76% from the prior year.
• Other financing activities for Q4 2025 stood at $1.3 million, up from $352000.0 in the prior quarter.
• Over the last five years, Other financing activities for INBX reached as high as $198.8 million in Q3 2023 and fell as low as -$197.7 million in Q4 2023.
• Historically, Other financing activities has averaged $12.4 million across 3 years, with a median of $17.1 million in 2024.